Resemblance-Ranking Peptide Library to Screen for Binders to Antibodies on a Peptidomic Scale
Authors:
- Felix JenneFJFelix Jenne
- Sergey BiniaminovSBSergey Biniaminov
- Nathalie BiniaminovNBNathalie Biniaminov
- Philipp MarquardtPMPhilipp Marquardt
- Clemens von Bojničić-KninskiCBClemens von Bojničić-Kninski
- Roman PopovRPRoman Popov
- Anja SeckingerASAnja Seckinger
- Dirk HoseDHDirk Hose
- Alexander Nesterov-MuellerANAlexander Nesterov-Mueller
Open Access
- 23 March 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (7) , 3515
Abstract
A novel resemblance-ranking peptide library with 160,000 10-meric peptides was designed to search for selective binders to antibodies. The resemblance-ranking principle enabled the selection of sequences that are most similar to the human peptidome. The library was synthesized with ultra-high-density peptide arrays. As proof of principle, screens for selective binders were performed for the therapeutic anti-CD20 antibody rituximab. Several features in the amino acid composition of antibody-binding peptides were identified. The selective affinity of rituximab increased with an increase in the number of hydrophobic amino acids in a peptide, mainly tryptophan and phenylalanine, while a total charge of the peptide remained relatively small. Peptides with a higher affinity exhibited a lower sum helix propensity. For the 30 strongest peptide binders, a substitutional analysis was performed to determine dissociation constants and the invariant amino acids for binding to rituximab. The strongest selective peptides had a dissociation constant in the hundreds of the nano-molar range. The substitutional analysis revealed a specific hydrophobic epitope for rituximab. To show that conformational binders can, in principle, be detected in array format, cyclic peptide substitutions that are similar to the target of rituximab were investigated. Since the specific binders selected via the resemblance-ranking peptide library were based on the hydrophobic interactions that are widespread in the world of biomolecules, the library can be used to screen for potential linear epitopes that may provide information about the cross-reactivity of antibodies.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (AOBJ655892)
This publication has 46 references indexed in Scilit:
- High-resolution Mapping of Linear Antibody Epitopes Using Ultrahigh-density Peptide MicroarraysMolecular & Cellular Proteomics, 2012
- Rituximab’s New Therapeutic Target: The Podocyte Actin CytoskeletonScience Translational Medicine, 2011
- Rituximab Targets Podocytes in Recurrent Focal Segmental GlomerulosclerosisScience Translational Medicine, 2011
- Printing protein arrays from DNA arraysNature Methods, 2008
- Pharmacokinetics of rituximab and its clinical use: Thought for the best use?Critical Reviews in Oncology/Hematology, 2007
- The epitope recognized by rituximabBlood, 2006
- Generation of High Density Protein Microarrays by Cell-free in Situ Expression of Unpurified PCR ProductsMolecular & Cellular Proteomics, 2006
- Generation of biologically active linear and cyclic peptides has revealed a unique fine specificity of rituximab and its possible cross-reactivity with acid sphingomyelinase-like phosphodiesterase 3b precursorBlood, 2006
- Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistanceOncogene, 2003
- Just add water! The effect of water on the specificity of protein-ligand binding sites and its potential application to drug designChemistry & Biology, 1996